TL;DR:
- Uninsured buyers can significantly reduce their GLP-1 medication costs through self-pay programs, telehealth bundles, and patient assistance programs. These alternatives rarely require paying retail prices, though cash costs vary widely by channel, drug, and dose. Verify the pharmacy’s licensure and your eligibility before purchasing.
Without insurance, many people pay far less than the $700–$1,100 retail list price, through manufacturer self-pay programs, telehealth plans, or patient assistance. The gap exists because these channels have become the primary access paths for uninsured patients, often undercutting retail by hundreds of dollars.
Here’s the short version of how to cut your cost fast:
- Compounded telehealth platforms bundle the clinician review, compounded medication, and shipping into one cash price. Compounded medications are not FDA-approved. Prices vary by platform; many advertise a lower first-month price that rises at renewal, and some charge more at higher doses.
- Manufacturer self-pay portals (NovoCare for semaglutide, LillyDirect for tirzepatide) publish transparent pricing for brand-name drugs, with introductory pricing sometimes as low as $149–$199 for starter doses and ongoing prices for maintenance doses typically $299–$499 depending on dose and drug.
- Patient Assistance Programs (PAPs) can supply brand-name GLP-1 medication at no cost for qualifying low-income uninsured patients — the paperwork takes time, but the savings are total.
- GoodRx and similar coupon platforms show real cash prices at retail pharmacies, including Walmart and Costco, though some savings cards require active commercial insurance to activate.
Where to start: check your income against PAP eligibility thresholds, compare self-pay portals for your specific drug and dose, and compare the full ongoing price (not just the first month) of any telehealth plan.
Table of Contents
- How much does each GLP-1 drug cost without insurance?
- Where can you actually buy GLP-1s without insurance?
- How to lower your GLP-1 out-of-pocket cost: what to try first
- Safety checklist: what to verify before you buy
- How to estimate your actual monthly GLP-1 cost
- What Medicare, Medicaid, and employer plans cover (and what they don’t)
- Key Takeaways
- What cash-pay GLP-1 patients actually encounter
- How Archie Health pricing works for uninsured patients
- Useful sources
- FAQ
How much does each GLP-1 drug cost without insurance?
Retail list prices are almost fictional for most uninsured patients. Few people actually pay them once you factor in manufacturer programs, telehealth bundles, and compounded alternatives. The table below shows realistic cash-pay ranges by drug.
| Drug | Typical monthly cash cost | Formulation | Dosing frequency | Best use case |
|---|---|---|---|---|
| Ozempic (semaglutide) | $800–$1,000 retail; $299–$499 via self-pay programs | Injectable pen | Once weekly | Type 2 diabetes (primary FDA indication) |
| Wegovy (semaglutide) | $700–$1,100 retail; $299–$499 via NovoCare self-pay | Injectable pen | Once weekly | Chronic weight management |
| Mounjaro (tirzepatide) | $700–$1,100 retail; $299–$449 via LillyDirect | Injectable pen | Once weekly | Type 2 diabetes (primary FDA indication) |
| Zepbound (tirzepatide) | $700–$1,100 retail; $299–$449 via LillyDirect vials | Injectable vial or pen | Once weekly | Chronic weight management |
| Rybelsus (semaglutide) | $800–$1,000 retail; varies by pharmacy | Oral tablet | Once daily | Type 2 diabetes; oral alternative to injectable |
| Compounded semaglutide/tirzepatide | Varies by platform. Example (Archie Health): semaglutide $159 first month, then $299/mo; tirzepatide $249 first month, then $399/mo | Injectable vial | Once weekly | Cash-pay option; not FDA-approved |
A few things worth noting about this table. Ozempic and Mounjaro carry FDA approval for type 2 diabetes, not obesity, so prescribing them for weight loss is off-label. Wegovy® (semaglutide) and Zepbound® (tirzepatide) are the weight-management-approved versions of the same active ingredients. That distinction matters for insurance coverage and sometimes for PAP eligibility, though it doesn’t change the cash price much.
Compounded semaglutide and tirzepatide sit at the bottom of the price range because they’re prepared by state-licensed compounding pharmacies rather than the original manufacturers. They are not FDA-approved finished drug products, which carries real quality implications covered in the safety section below.
On the Wegovy cost breakdown side, NovoCare’s self-pay program has published introductory pricing that can run significantly below the retail sticker. LillyDirect does the same for Zepbound vials, with published per-dose pricing that gives you a predictable monthly benchmark.
Pro Tip: Introductory prices often apply only to the first month or the lowest dose. On many programs the price rises at renewal or as the dose increases. Always ask what the ongoing price is at your target dose, and whether the plan renews automatically, before committing to a program.
Where can you actually buy GLP-1s without insurance?
The channel you choose affects price, speed, privacy, and regulatory risk. Here’s how each one works in practice.
Manufacturer self-pay portals
NovoCare (Novo Nordisk) and LillyDirect (Eli Lilly) both publish cash-pay pricing for their branded drugs. You get an FDA-approved product at a predictable price, often fulfilled through retail pharmacy partners including large chains. Costco and Walmart pharmacies are commonly listed as pick-up locations for these programs. The tradeoff: you still need a valid prescription, and the price is higher than compounded alternatives.
Telehealth bundled clinics
These platforms combine the provider visit, prescription, and medication shipment into a single all-in price. Compounded telehealth programs list cash prices upfront; the timeline depends on clinician review and pharmacy shipping and is often one to two weeks. Convenience is the main advantage here. The medication is compounded, not branded, so quality depends entirely on the pharmacy’s licensure and testing practices.
Retail pharmacies (Walmart, Costco, and others)
Walmart and Costco pharmacies fill standard prescriptions and can process manufacturer self-pay program fills. Costco is specifically noted in some self-pay program rollouts. You can use GoodRx to look up cash prices at any major chain before you walk in. Prices vary by location and by which programs the pharmacy participates in, so calling ahead saves time.
GoodRx and coupon platforms
GoodRx shows real cash prices at participating pharmacies and sometimes surfaces prices lower than what you’d pay without a coupon. One important caveat: some savings cards require active commercial insurance to activate, so read the eligibility terms before assuming you qualify. GoodRx’s cash-pay lookup works for uninsured patients; the branded savings cards often don’t.
Compounding pharmacies (503A and 503B)
503A pharmacies compound for individual patients with a prescription; 503B outsourcing facilities produce larger batches. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025. Compounding now relies on patient-specific prescriptions under section 503A, where a prescriber determines that a compounded preparation is appropriate for an individual patient. Prices are often lower here, but compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality.
Patient Assistance Programs (PAPs)
PAPs are run by the manufacturers themselves and can provide brand-name medication at no cost to qualifying low-income uninsured patients. Novo Nordisk and Eli Lilly both operate PAPs. Income limits apply (typically at or below 400% of the federal poverty level, though thresholds vary), and the application process involves paperwork and a provider signature. Processing takes weeks, not days.
| Channel | Typical monthly cost | Time to start | Regulatory status | Privacy note |
|---|---|---|---|---|
| Manufacturer self-pay portal | $299–$499 | 1–3 days | FDA-approved branded drug | Cash pay; no insurance claim filed |
| Telehealth compounded bundle | Varies by platform and dose | About 1–2 weeks | Compounded; not FDA-approved | Cash pay; no insurance claim filed |
| Retail pharmacy (cash price) | $800–$1,100 | Same day (with Rx) | FDA-approved branded drug | May appear in pharmacy benefit records |
| GoodRx at retail | Varies; often $700–$1,100 | Same day (with Rx) | FDA-approved branded drug | GoodRx has its own data practices |
| PAP (manufacturer assistance) | $0 for qualifying patients | 2–6 weeks | FDA-approved branded drug | No insurance claim; income verification required |
| Compounding pharmacy (with a prescription) | Varies by pharmacy and dose | Varies | Compounded; not FDA-approved | Cash pay; no insurance claim filed |
How to lower your GLP-1 out-of-pocket cost: what to try first
Think of this as an order of operations, not a menu. Work through it top to bottom and stop when you find the path that fits your situation.
- Check PAP eligibility first. If your household income falls within the manufacturer’s threshold, you could pay nothing. Visit NovoCare.com or LillyDirect.com, look for the patient assistance section, and run the eligibility screener before spending a dollar anywhere else.
- Compare manufacturer self-pay portals. If you don’t qualify for a PAP, NovoCare and LillyDirect publish their cash prices. These are FDA-approved branded drugs at predictable prices, often $299–$499 for maintenance doses.
- Get a telehealth compounded bundle quote. If the brand price is still too high, a licensed telehealth platform may offer compounded medication, which is not FDA-approved. Compare the first-month and renewal prices, and confirm the pharmacy’s state licensure before ordering.
- Use GoodRx to compare retail pharmacy prices. Even if you end up using a manufacturer program, checking GoodRx first gives you a baseline. It takes two minutes and occasionally surfaces prices lower than you’d expect at a specific chain.
- Check whether you can use HSA/FSA funds. You may be able to pay with an HSA or FSA card; eligibility depends on your plan administrator. Confirm with your administrator and check that the program accepts these cards before assuming it does.
- Ask your clinician about timing while waiting for PAP approval. PAP processing takes weeks. Your clinician can advise whether to wait or start another option in the meantime.
What to have ready for each path:
- Prescription from a licensed provider (required for all channels)
- BMI documentation or diagnosis records (needed for weight-management indications)
- Photo ID and proof of income (required for PAPs)
- HSA/FSA card or account details (if applying pre-tax funds)
Pro Tip: Paying cash through a manufacturer self-pay portal or telehealth program keeps your prescription out of employer self-insured claims data. If privacy from your employer matters to you, cash-pay channels are the cleaner route.
Safety checklist: what to verify before you buy
The lowest price is not always the safest price. Here’s what to check before you hand over payment.
FDA-approved branded drugs (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus) go through rigorous manufacturing standards and carry consistent dosing. When you buy through a manufacturer self-pay portal or a licensed retail pharmacy, you’re getting the finished product as tested and approved.
Compounded preparations are a different category. They’re legal when prepared by a state-licensed compounding pharmacy, but they are not FDA-approved finished drug products. That means no FDA review of the specific batch’s safety, potency, or sterility. Quality depends entirely on the compounding pharmacy’s own practices.
Verify before you buy: Ask any compounding pharmacy for their state pharmacy board license number, the lot number of your specific batch, and a certificate of analysis (CoA) from a third-party lab. A legitimate pharmacy will provide all three without hesitation. If a seller refuses or can’t produce these, walk away.
Red flags that signal counterfeit or unsafe supply:
- No prescription required
- A price far below what licensed pharmacies and telehealth programs typically charge, with no explanation
- Seller declines to name the compounding pharmacy or provide license details
- Product ships from outside the United States
- Website has no licensed provider contact information
The FDA page on concerns with unapproved GLP-1 drugs used for weight loss explains the risks of compounded and counterfeit products. Check the FDA site directly rather than relying on a seller’s claims. Archie Health’s GLP-1 medication safety information page covers side effects and safety information for the medications it offers.
How to estimate your actual monthly GLP-1 cost
Three scenarios, real numbers, and the assumptions behind them.
Scenario A: Compounded telehealth plan (example: Archie Health)
- Compounded semaglutide: $159 first month, then $299/mo
- Compounded tirzepatide: $249 first month, then $399/mo
- Includes clinician review, coaching, medication if prescribed, supplies, and shipping; the price is the same at every dose
- Plans renew automatically until you cancel
- Other platforms price differently; some charge separately for supplies or shipping, or charge more at higher doses
Scenario B: Manufacturer self-pay brand (ongoing)
- LillyDirect Zepbound vial (maintenance dose): $299–$449/month
- Provider visit (if not bundled): $50–$150 one-time or quarterly
- Pen needles or vial supplies: $10–$20/month
- Total estimated ongoing: $310–$470/month
Scenario C: Retail pharmacy with GoodRx
- GoodRx cash price at a major chain: $700–$1,100/month (varies by drug and location)
- Provider visit: $100–$200 if not already established
- Total estimated: $800–$1,300/month
| Scenario | First-month estimate | Ongoing monthly estimate | Regulatory status |
|---|---|---|---|
| A: Compounded telehealth (Archie Health example) | $159–$249 | $299–$399 | Compounded; not FDA-approved |
| B: Manufacturer self-pay brand | $310–$470 | $310–$470 | FDA-approved branded drug |
| C: Retail pharmacy (GoodRx) | $800–$1,300 | $800–$1,300 | FDA-approved branded drug |
Hidden costs to include in your math:
- Shipping fees (some telehealth platforms charge $10–$30/month; others include it)
- Quarterly monitoring labs if your provider requires them ($50–$150 out of pocket)
- Separate platform fees on some telehealth programs (not all charge these; confirm upfront)
- Dose escalation: on some platforms the price rises as your dose increases, so ask before you start
Prices shift. Manufacturer programs update their pricing, compounded prices vary by platform, and GoodRx prices vary by pharmacy and week. Verify current pricing directly with the program before committing.
What Medicare, Medicaid, and employer plans cover (and what they don’t)
Commercial insurance plans typically cover GLP-1 drugs for type 2 diabetes (Ozempic, Mounjaro) more readily than for obesity (Wegovy, Zepbound). Prior authorization is almost universal, and many employer plans explicitly exclude weight-loss drugs even when a patient has obesity as a diagnosed condition. If your plan denies coverage, you’re in the same cash-pay position as an uninsured patient.
Medicare has historically excluded weight-loss drugs from Part D coverage. CMS has been developing a Medicare GLP-1 bridge program that could expand access, but coverage rules are evolving. Medicare beneficiaries should check CMS directly for current demonstration program eligibility.
Medicaid coverage varies by state. Some states cover GLP-1s for obesity; others cover only the diabetes indications. Check your state Medicaid formulary directly.
For uninsured readers: cash-pay channels exist regardless of your insurance status, and the manufacturer self-pay programs don’t require you to have or have had insurance. The pricing and billing FAQ at Archie Health covers common questions about what to expect when starting a cash-pay plan.
- If you’re on Medicare: check CMS’s bridge program page for current eligibility.
- If you’re on Medicaid: look up your state’s formulary for obesity-indication coverage.
- If you’re uninsured: manufacturer self-pay portals and telehealth bundles are your primary routes; PAPs are worth checking first if your income qualifies.
Key Takeaways
Uninsured patients who use manufacturer self-pay programs or licensed telehealth bundles rarely need to pay retail list price, with realistic monthly costs varying depending on the drug, dose, and channel.
| Point | Details |
|---|---|
| Realistic monthly range | Self-pay and telehealth channels usually cost far less than the $700–$1,100 retail list price. Compare the ongoing monthly price, not just the first month. |
| Compounded telehealth | Compounded bundles are often cheaper than brand-name drugs but are not FDA-approved; many have a lower first-month price that rises at renewal. |
| Cheapest possible route | Patient Assistance Programs can provide brand-name GLP-1 medication at no cost for qualifying low-income uninsured patients. |
| Safety first | Always verify a compounding pharmacy’s state license, lot number, and certificate of analysis before purchasing compounded medication. |
| Archie Health option | Archie Health offers compounded semaglutide ($159 first month, then $299/mo) and compounded tirzepatide ($249 first month, then $399/mo). Plans renew automatically; clinician review is included in the plan price. Archie Health does not bill insurance. |
What cash-pay GLP-1 patients actually encounter
One common surprise isn’t the price itself. It’s that cash-pay removes the prior authorization step entirely. On telehealth platforms, clinician review often takes a few business days (on Archie Health, usually within 1–2 business days), and for people who’ve spent months on prior authorization denials, that can change the calculation.
Another is PAP eligibility. Some people who assume they earn too much to qualify fall within the threshold when they run the screener. Income limits are set by each manufacturer, and the application is worth the paperwork if there’s any chance you qualify.
The privacy angle is less discussed but genuinely matters to some patients. When you pay cash through a manufacturer portal or telehealth program, the prescription doesn’t flow through your employer’s self-insured claims data. For people on employer-sponsored plans who are considering switching to cash-pay, that’s a real consideration worth factoring in alongside the price.
The thing that catches people off guard: renewal and dose escalation costs. Many introductory offers cover only the first month or the lowest dose. Plan for the ongoing monthly price from the beginning rather than anchoring to the introductory price.
How Archie Health pricing works for uninsured patients
Archie Health is a cash-pay telehealth platform. It does not bill insurance, including Medicare and Medicaid. Through Archie Health, independent licensed clinicians may prescribe compounded semaglutide or compounded tirzepatide, which are not FDA-approved and are not Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Archie Health does not sell brand-name medications.
- Compounded semaglutide: $159 first month, then $299/mo. 3-month plan: $747 billed every 3 months. 6-month plan: $1,344 billed every 6 months.
- Compounded tirzepatide: $249 first month, then $399/mo. 3-month plan: $1,152 billed every 3 months. 6-month plan: $2,142 billed every 6 months.
Plans renew automatically until you cancel. The plan price includes clinician review, coaching and care-team messaging, medication if prescribed, supplies, and shipping, and it is the same at every dose. All costs are shown before checkout. A prescription is required, and not everyone qualifies; an independent licensed clinician decides whether treatment is appropriate.
Want to see whether you’re eligible? Start your intake.
Useful sources
Prices and program rules change. Verify any figure directly with the source before acting on it.
- NovoCare Patient Assistance Program — Novo Nordisk’s official portal for Ozempic and Wegovy self-pay and assistance program eligibility.
- LillyDirect — Eli Lilly’s direct self-pay portal for Mounjaro and Zepbound vial pricing; publicly posted per-dose pricing.
- CMS Medicare GLP-1 Bridge Program — Current CMS guidance on Medicare coverage developments for GLP-1 medications.
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss — FDA information on compounded and unapproved GLP-1 products.
Prices listed in this article reflect data available as of 2026. Confirm current pricing and program availability directly with each source before making a purchase decision.
FAQ
Who has the cheapest GLP-1 option without insurance?
Qualifying low-income uninsured patients can receive brand-name GLP-1 medication at no cost through manufacturer Patient Assistance Programs from Novo Nordisk or Eli Lilly. For those who don’t qualify, compounded telehealth plans are often the lowest cash-pay option, though they are not FDA-approved and prices vary by platform, renewal terms, and dose.
How are people getting GLP-1 medications without insurance?
The most common routes are manufacturer self-pay portals (NovoCare, LillyDirect), licensed telehealth platforms that bundle the visit and compounded medication, and retail pharmacies using GoodRx cash pricing. PAPs are also widely used by patients who meet income eligibility requirements.
How much is a GLP-1 at Costco without insurance?
Costco pharmacies participate in some manufacturer self-pay program fulfillments, and cash prices vary by drug and location. Using GoodRx at Costco’s pharmacy can surface current cash prices; call the pharmacy directly with your specific drug and dose for an accurate quote, as prices shift frequently.
How much is Ozempic at Walmart without insurance?
Walmart pharmacies fill Ozempic at retail cash prices that typically run $800–$1,000/month without a discount program. Checking GoodRx before filling at Walmart can lower that figure, though the savings vary. NovoCare’s self-pay program, fulfilled through retail partners, often offers a better price than the standard Walmart cash price.
Does Archie Health accept patients without insurance?
Yes. Archie Health is cash-pay only and does not bill insurance, including Medicare and Medicaid. Compounded semaglutide is $159 for the first month, then $299/mo; compounded tirzepatide is $249 for the first month, then $399/mo. Plans renew automatically until you cancel, and the price includes clinician review, coaching, medication if prescribed, and shipping. These compounded medications are not FDA-approved.
This article provides general information about GLP-1 medication costs and purchasing options. It is not medical or financial advice. Confirm current program rules, pricing, and your eligibility with the relevant manufacturer, pharmacy, or a licensed healthcare provider before making any treatment decision.